IHC detects the HER2 protein on a tumour’s cell surface, providing a measure of overexpression, while ISH, including fluorescence (FISH) and chromogenic (CISH) approaches, identifies gene amplification by quantifying the ERBB2 copy numbers relative to chromosome 17. Here, ERBB2 is linked to neoplasm.